These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 26749702)

  • 1. [When and why start insulin in type 2 diabetes?].
    Potier L
    Rev Prat; 2015 Oct; 65(8):1042-5. PubMed ID: 26749702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [General insulin therapy practice in type 2 diabetes mellitus].
    Wiesli P; Spinas GA
    Ther Umsch; 2002 Aug; 59(8):402-9. PubMed ID: 12235732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosing of insulin glargine in the treatment of type 2 diabetes.
    Barnett A
    Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetes mellitus type II: when convert to insulin?].
    Bianda TL; Spinas GA
    Praxis (Bern 1994); 1997 Sep; 86(38):1453-7. PubMed ID: 9381045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective switch from premixed to basal-prandial insulin to achieve glycemic goals in type 2 diabetes.
    Lavernia F
    Postgrad Med; 2010 May; 122(3):28-32. PubMed ID: 20463411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Making the transition from oral to insulin therapy.
    Riddle MC
    Am J Med; 2005 May; 118 Suppl 5A():14S-20S. PubMed ID: 15850549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes.
    Parkner T; Møller MK; Chen JW; Laursen T; Jørgensen C; Smedegaard JS; Lauritzen T; Christiansen JS
    Diabetes Obes Metab; 2008 Jul; 10(7):556-63. PubMed ID: 17593233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes mellitus--guidelines for initiating insulin therapy.
    Yeap BB
    Aust Fam Physician; 2007 Jul; 36(7):549-53. PubMed ID: 17619673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine-tuning therapy with basal insulin for optimal glycemic control in type 2 diabetes: a review.
    Dailey G
    Curr Med Res Opin; 2004 Dec; 20(12):2007-14. PubMed ID: 15701217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recommendations concerning the initial regimen and dose adjustments of insulin therapy for type 2 diabetes mellitus].
    Houweling ST; Timmerman GJ; Hoogstraten MF; Ubink-Veltmaat LJ; Verhoeven S; Bilo HJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1823-7. PubMed ID: 12382366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.
    Ross SA; Zinman B; Campos RV; Strack T;
    Clin Invest Med; 2001 Dec; 24(6):292-8. PubMed ID: 11767232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
    Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
    Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of regimens of insulin therapy in type 2 diabetes mellitus subjects with secondary failure.
    Zargar AH; Masoodi SR; Laway BA; Wani AI; Bashir MI
    J Assoc Physicians India; 2002 May; 50(5):641-6. PubMed ID: 12186116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin therapy in the type 2 obese diabetic patient. Supplementing the deficit].
    Matthaei S; Häring HU
    MMW Fortschr Med; 2001 May; 143(21):35-7. PubMed ID: 11420829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs.
    Yang W; Ji Q; Zhu D; Yang J; Chen L; Liu Z; Yu D; Yan L
    Diabetes Care; 2008 May; 31(5):852-6. PubMed ID: 18268073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Step-wise drug therapy in type 2 diabetes mellitus].
    König K; Schatz H
    Z Arztl Fortbild Qualitatssich; 1998 Sep; 92(7):467-73. PubMed ID: 9842691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral antidiabetic agents: 2004.
    Lebovitz HE
    Med Clin North Am; 2004 Jul; 88(4):847-63, ix-x. PubMed ID: 15308382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.
    Hausmann M; Dellweg S; Osborn C; Heinemann L; Buchwald A; Rosskamp R; Genova P; Heise T
    Diabetes Obes Metab; 2006 Sep; 8(5):574-80. PubMed ID: 16918593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.